pregnadienediols

Preferred Label : pregnadienediols;

MeSH definition : Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.;

MeSH synonym : dihydroxypregnadienes;

Is substance : O;

Details

Origin ID

D011244;

UMLS CUI

C0032958;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- pregnadienediols [MeSH concept]
Related MeSH Supplementary Concept(s)
- (20S)-20-(N,N-dimethylamino)-3beta-(tigloylamino)-5alpha-pregn-14-en-2beta,4beta-diol [MeSH Supplementary Concept]
- (20S)-20-(N,N-dimethylamino)-3beta-methoxy-pregn-5,16-diene [MeSH Supplementary Concept]
- 11,20-dihydroxy-3-oxopregna-4,17(20)-dien-21-al [MeSH Supplementary Concept]
- 11beta,17alpha-dihydroxy-21-methylpregna-4-diene-3,20-dione-17-butyrate [MeSH Supplementary Concept]
- 15,17-dihydroxypregna-4,6-diene-3,20-dione [MeSH Supplementary Concept]
- 16-alpha-methyldichlorosone [MeSH Supplementary Concept]
- 20-(3-hydroxy-3-methylbutyloxy)pregna-5,7-diene-1,3-diol [MeSH Supplementary Concept]
- 3,21-dihydroxypregna-5,7-dien-20-one [MeSH Supplementary Concept]
- 7 alpha,12 alpha-dihydroxy-3-oxopregna-1,4-diene-20-carboxylic acid [MeSH Supplementary Concept]
- GR 2-2132 [MeSH Supplementary Concept]
- QMF149 [MeSH Supplementary Concept]
- VBP15 compound [MeSH Supplementary Concept]
- anecortave acetate [MeSH Supplementary Concept]
- clogestone [MeSH Supplementary Concept]
- cyclomethasone [MeSH Supplementary Concept]
- diendiol [MeSH Supplementary Concept]
- fluazacort [MeSH Supplementary Concept]
- fluodexan [MeSH Supplementary Concept]
- flupamesone [MeSH Supplementary Concept]
- meclorisone dibutyrate [MeSH Supplementary Concept]
- mepregenol diacetate [MeSH Supplementary Concept]
- methyl 21-acetyloxy-3,20-dioxo-11,17-dihydroxy-9-fluoro-1,4-pregnadiene-16-carboxylate [MeSH Supplementary Concept]
- oxazacort [MeSH Supplementary Concept]
- pregna-4,9(11)-diene-17alpha,21-diol-3,20-dione acetates [MeSH Supplementary Concept]
- tralonide [MeSH Supplementary Concept]
- win 44577 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients